Inventor
MICHAEL HOWELL
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations44%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data13%
PatentTitleYear
12,589,096Ruxolitinib formulation for reduction of itch in atopic dermatitis202612,396,993Ruxolitinib formulation for reduction of itch in atopic dermatitis202512,233,067Topical treatment of vitiligo by a JAK inhibitor202512,020,784Macro-based diagnoses for anatomic pathology202411,972,845Macro-based diagnoses for anatomic pathology202411,602,536Topical treatment of vitiligo by a JAK inhibitor202311,590,137Ruxolitinib formulation for reduction of itch in atopic dermatitis202311,590,138Topical treatment of vitiligo by a jak inhibitor202311,510,923Ruxolitinib formulation for reduction of itch in atopic dermatitis2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to INCYTE CORP (7)· patent assignee history
2022–2026Based in US· patent location history
2024Patents assigned to CEREBRUM HOLDING CORP (2)· patent assignee history
2024Patents assigned to CEREBRUM CORP (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 7 | 2022–2026 |
| CEREBRUM HOLDING CORP | 2 | 2024 |
| CEREBRUM CORP | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |